Default
Allergy and immunology
Anaesthesia
Basic research
Cardiovascular medicine
Complementary medicine and alternative therapies
Critical care / intensive care
Dentistry / oral medicine
Dermatology
Emergency medicine
Endocrinology
Epidemiology
Ethics
Evidence-based medicine
Gastroenterology
Genetics
Geriatric medicine / aging
Haematology / blood transfusion
Health economics
Health policy
History of medicine
Infectious diseases
Internal medicine
Laboratory medicine
Legal and forensic medicine
Medical education
Medical informatics
Neurology
Nursing
Nutrition and metabolism
Obstetrics and gynaecology
Occupational and environmental medicine
Oncology
Ophthalmology
Organisation of health care
Otolaryngology / head and neck surgery
Paediatrics
Palliative care
Pathology
Patient-physician relationship
Pharmacology and therapeutics
Primary care, family medicine
Psychiatry and psychotherapy
Psychosomatics
Public health
Quality of care
Radiology
Rehabilitation medicine
Renal medicine
Respiratory medicine
Rheumatology
Sexual medicine
Sports medicine
Statistics and research methods
Surgery
Transplantation
Travel medicine
Urology
COVID-19 and cardiovascular disease: what have we learned?
As of 10 December, 82,127 citations were found in PubMed on COVID-19 and 5285 when “COVID-19 and cardiovascular disease” were used as search words. Many cardiovascular societies have also released statements regarding COVID-19. What have we learned from this incredible scientific excitement?
In the eye of the hurricane: the Swiss COVID-19 pandemic stepwise shutdown approach in organ donation and transplantation
The Swiss stepwise shutdown approach in organ donation and transplantation helped to maintain a limited national organ procurement and vital organ transplant activity, avoiding a complete nationwide shutdown of organ donation and transplant activity.
SARS-CoV-2 / COVID-19 in patients on the Swiss national transplant waiting list
The impact of coronavirus disease 2019 (COVID-19) on patients listed for solid organ transplantation has not been systematically investigated to date. The authors of this study assessed occurrence and effects of infections with SARS-CoV-2 on patients on the Swiss national waiting list for solid organ transplantation.
Impact of the COVID-19 pandemic on acute coronary syndromes
Prolonged delays from symptom onset to first medical contact and a decline in overall ACS incidence were observed during the first wave of the COVID-19 pandemic, with a higher threshold to call for help among ACS patients.
Cardiovascular aspects of COVID-19
In this review, findings and debates relating to the diverse aspects of cardiovascular involvement of COVID-19 are summarised and put into perspective. The authors review evidence for the role of the renin-angiotensin-aldosterone system (RAAS), the risk of pre-existing cardiovascular disease in COVID-19 susceptibility and course, and the mechanism of acute and long-term myocardial injury.
Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs
Prescribing experimental therapies for COVID-19 was not associated with a reduced length of hospital stay and might have increased the pressure put on healthcare systems.
The Swiss STAR trial – an evaluation of target groups for sexually transmitted infection screening in the sub-sample of women
HIV and HCV do not appear to pose a major public health problem among female sex workers in Switzerland, whereas vaccination against HBV should be promoted. Female sex workers showed high rates of sexually transmitted infections requiring treatment to reduce transmission to clients and/or steady partners. Female sex workers should be offered low-cost or free STI screening as a public health priority.
The Swiss STAR trial – an evaluation of target groups for sexually transmitted infection screening in the sub-sample of men
Among men who have sex with men (MSM), but not among other multi-partner men, sexually transmitted infections, mostly asymptomatic, are common. Given the high risk of onward transmission, low-cost or free routine screening of multi-partner MSM is a public health priority.
Optimal allocation of limited test resources for the quantification of COVID-19 infections
The proposed methodology can lead to vastly less uncertain predictions for the spread of the disease, thus improving estimates of the effective reproduction number and the future number of unreported infections. This information can provide timely and systematic guidance for the effective identification of infectious individuals and for decision-making regarding lockdown measures and the distribution of vaccines.
Early evidence of effectiveness of digital contact tracing for SARS-CoV-2 in Switzerland
Digital contact tracing is an effective complementary tool for controlling the spread of SARS-CoV-2. Continued technical improvement and international compatibility can further increase the efficacy, particularly also across country borders.
